Cardiac Guidance vs ElucidVivo A.3

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cardiac Guidance

by Caption Health

ElucidVivo A.3

by Elucid

AI Verdict

These tools are adjacent in the cardiovascular AI space, addressing different stages and modalities of cardiac assessment. Cardiac Guidance focuses on empowering healthcare professionals to acquire and interpret diagnostic-quality cardiac ultrasound images at the point of care. In contrast, ElucidVivo A.3 specializes in quantitative analysis of arterial plaque composition and stability from CT angiography to aid in atherosclerosis patient stratification.

Choose Cardiac Guidance if…

Choose Cardiac Guidance if your primary goal is to democratize access to cardiac assessments by enabling healthcare professionals, including those without extensive ultrasound experience, to acquire diagnostic-quality cardiac ultrasound images at the point of care. This tool is ideal for settings focused on early disease detection and rapid, accessible cardiac evaluations, leveraging real-time AI guidance for image acquisition and automated quality assessment.

View Cardiac Guidance →

Choose ElucidVivo A.3 if…

Choose ElucidVivo A.3 if you require advanced, quantitative analysis of arterial plaque composition and stability from CT angiography to stratify patients with atherosclerosis and optimize treatment decisions. This system is best suited for specialists needing detailed visualization of plaque characteristics, including lipid-rich necrotic core and calcifications, validated against histology, to inform complex cardiovascular and vascular surgery interventions.

View ElucidVivo A.3 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cardiac Guidance	ElucidVivo A.3
Deployment	Caption Guidance is deployed in acute point-of-care settings, including emergency and anesthesiology departments and critical care units. It is also used in doctors' offices and can be used for at-home care.	Cloud and on-premise secure deployment.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Cardiac Guidance

Cardiac Guidance (Tool A) is explicitly designed to empower non-expert ultrasound users with real-time AI guidance, turn-by-turn probe instructions, and automated quality assessment, significantly simplifying a complex procedure. This focus on making advanced imaging accessible to a broader range of healthcare professionals gives it a clear advantage in usability.

Clinical Value

ElucidVivo A.3

ElucidVivo A.3 (Tool B) offers a highly specialized and quantitative analysis of arterial plaque composition and stability from CT angiography, validated against ground-truth histology. Its ability to objectively quantify plaque components and derive FFRct provides deeper, more precise diagnostic and prognostic insights for atherosclerosis, directly optimizing treatment decisions.

Pricing & Value

Cardiac Guidance

Both tools require contacting the vendor for pricing, limiting transparency. However, Cardiac Guidance (Tool A) explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are crucial for healthcare organizations and contribute significantly to its overall value and readiness for deployment in a regulated environment.

Enterprise Readiness

Cardiac Guidance

Both tools are FDA-cleared and designed for integration within healthcare environments. Cardiac Guidance (Tool A) explicitly confirms HIPAA compliance and the provision of a BAA, which are fundamental requirements for enterprise deployment in healthcare and offer greater assurance regarding data security and regulatory adherence.

Innovation

ElucidVivo A.3

While Cardiac Guidance (Tool A) innovates by democratizing cardiac ultrasound acquisition, ElucidVivo A.3 (Tool B) presents a more profound innovation in diagnostic precision. Its AI-powered, histologically validated quantitative analysis of arterial plaque composition and the derivation of FFRct offer novel and deeper insights into atherosclerosis, pushing the boundaries of non-invasive cardiovascular assessment.

Support & Docs

Cardiac Guidance

Cardiac Guidance (Tool A) explicitly mentions the availability of an electronic Operator's Manual accessible both for instructions and within the Vscan Air app, indicating readily available user documentation. In contrast, the provided information for ElucidVivo A.3 (Tool B) does not detail specific support channels or documentation availability.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cardiac Guidance	ElucidVivo A.3
Name	Cardiac Guidance	ElucidVivo A.3
Company	Caption Health	Elucid Bioimaging
Primary Clinical Focus	Acquiring and interpreting diagnostic-quality cardiac ultrasound images at the point of care for early disease detection and accessible cardiac care.	Quantitative analysis of arterial plaque composition and stability from CT angiography for atherosclerosis patient stratification and optimized treatment decisions.
Input Imaging Modality	Cardiac ultrasound images	CT angiography
Key AI Functionality	Real-time AI guidance for cardiac ultrasound image acquisition, automated quality assessment, auto-capture of diagnostic-quality images, automated left ventricular ejection fraction (EF) calculation.	AI-powered quantitative analysis of arterial plaque, visualization of lesion-level plaque composition, 3D visualization of highlighted vessels, derivation of fractional flow reserve (FFRct).
Specific Measurements/Outputs	Automated left ventricular ejection fraction (EF) calculation, support for 10 standard echocardiographic views.	Objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images; derives fractional flow reserve (FFRct).
Intended User/Skill Level	Healthcare professionals, designed for use by non-expert ultrasound users.	Physicians (aids in atherosclerosis patient stratification and optimizes treatment decisions).

Videos

Demos, reviews, and walkthroughs featuring Cardiac Guidance and ElucidVivo A.3.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What imaging modalities are utilized by Cardiac Guidance and ElucidVivo A.3?

Cardiac Guidance is a software accessory integrated with compatible general purpose diagnostic ultrasound systems, enabling the acquisition and interpretation of cardiac ultrasound images. ElucidVivo A.3 is an AI-powered medical image analysis system that provides quantitative analysis of arterial plaque from CT angiography.

What specific cardiovascular conditions or assessments do these tools primarily address?

Cardiac Guidance focuses on empowering healthcare professionals to acquire and interpret diagnostic-quality cardiac ultrasound images for early disease detection and accessible cardiac care, including automated left ventricular ejection fraction (EF) calculation. ElucidVivo A.3 assists physicians in atherosclerosis patient stratification and optimizes treatment decisions by offering detailed visualization and measurement of arterial plaque composition and stability from CT angiography.

Are these tools designed for use at the point of care or for post-acquisition image analysis?

Cardiac Guidance is designed to empower healthcare professionals to acquire and interpret cardiac ultrasound images at the point of care. ElucidVivo A.3 is an AI-powered medical image analysis system that performs quantitative analysis of arterial plaque from previously acquired CT angiography images, indicating post-acquisition analysis.

What level of user expertise is targeted by each tool?

Cardiac Guidance is designed for use by non-expert ultrasound users, providing real-time AI guidance and turn-by-turn on-screen probe movement instructions. ElucidVivo A.3 assists trained physicians in the stratification of patients identified to have atherosclerosis and provides tools for measurement and visualization of arterial vessels.

What are the key quantitative outputs or analyses provided by each tool?

Cardiac Guidance provides automated quality assessment with a 'Quality Meter' and automated left ventricular ejection fraction (EF) calculation. ElucidVivo A.3 objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images, visualizes lesion-level plaque composition, and derives fractional flow reserve (FFRct) based on vessel wall vasodilative capacity.

How do these tools integrate into existing clinical environments?

Cardiac Guidance is a software accessory integrated with compatible general purpose diagnostic ultrasound systems. ElucidVivo A.3 is a software application that integrates with PACS/EMR, allowing for the processing, review, analysis, communication, and media interchange of multi-dimensional digital images acquired from CT imaging devices.